Nektar Therapeutics

NKTR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$44,252$35,277$88,227$25,218
Short-Term Investments$210,974$268,339$416,750$708,737
Receivables$1,609$2,252$8,404$22,492
Inventory$0$16,101$19,202$15,801
Other Curr. Assets$4,457$8,732$13,385$23,333
Total Curr. Assets$261,292$330,701$545,968$795,581
Property Plant & Equip (Net)$11,824$36,863$85,886$177,535
Goodwill$0$0$76,501$76,501
Intangibles$0$0$0$0
Long-Term Investments$26,087$25,825$0$64,828
Tax Assets$0$0$0$0
Other NC Assets$4,647$4,644$2,245$2,744
Total NC Assets$42,558$67,332$164,632$321,608
Other Assets$0$0$0$0
Total Assets$303,850$398,033$710,600$1,117,189
Liabilities
Payables$11,560$9,848$12,980$9,747
Short-Term Debt$19,868$19,259$18,667$17,441
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$29,972$22,162$36,557$58,012
Total Curr. Liab.$61,400$51,269$68,204$85,200
LT Debt$82,696$98,517$112,829$125,736
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$99,017$117,260$162,929$226,745
Total NC Liab.$181,713$215,777$275,758$352,481
Other Liabilities$0$0$0$0
Cap. Leases$102,564$117,776$131,496$143,177
Total Liabilities$243,113$267,046$343,962$437,681
Equity
Pref Stock$0$0$0$0
Common Stock$19$19$19$19
Retained Earnings-$3,596,210-$3,477,249-$3,201,193-$2,832,995
AOCI$61$80-$6,907-$4,157
Other Equity$3,656,867$3,608,137$3,574,719$3,516,641
Total Equity$60,737$130,987$366,638$679,508
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$303,850$398,033$710,600$1,117,189
Net Debt$58,312$82,499$43,269$117,959